Are you planning to invest in a new infusion center but worried about site neutral payments, 340B cuts, drug reimbursements, and oral chemo?
To help you out, we've designed the Infusion Center Pro Forma tool, which incorporates 340B cuts and site neutral payments in an easy to understand, customizable format, allowing organizations to evaluate the net present value of a new infusion facility and thereby helping organizations make the business case decision.
The Infusion Center Pro forma will help you estimate:
- Investments and operating costs
- Volumes and reimbursements
- NPV at three sites: HOPD, non-excepted HOPD, and freestanding